To test this hypothesis, we employed mouse tracheal rings which can be readily attained and compared TMEM16A antagonists versus the β-agonist isoproterenol for bronchodilation after various challenges meant to reflect the situation of severe asthma with poorly controlled inflammation and airway hyperresponsiveness (AHR), which reflects increased sensitivity to contractants. The gene discussed is ANO1; the disease is airway hyperresponsiveness.